PROCEPT BioRobotics (PRCT) Enterprise Value (2021 - 2026)

PROCEPT BioRobotics (PRCT) has reported Enterprise Value for 6 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 64.89% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 64.89% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 63.52% from the prior year.
• Enterprise Value was $1.0 billion for Q2 2026 at PROCEPT BioRobotics, down from $1.2 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $4.1 billion in Q4 2024 and troughed at $1.0 billion in Q2 2026.
• A 5-year average of $2.0 billion and a median of $1.6 billion in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value soared 1420.26% in 2022 and sank 64.89% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $1.6 billion in 2022, then climbed by 14.09% to $1.9 billion in 2023, then soared by 117.69% to $4.1 billion in 2024, then plunged by 63.52% to $1.5 billion in 2025, then plunged by 31.5% to $1.0 billion in 2026.
• The last three Enterprise Value figures came in at $1.0 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.